These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23256847)

  • 1. Use of next generation sequencing technologies in research and beyond: are participants with mental health disorders fully protected?
    Groisman IJ; Mathieu G; Godard B
    BMC Med Ethics; 2012 Dec; 13():36. PubMed ID: 23256847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consenting for current genetic research: is Canadian practice adequate?
    Jaitovich Groisman I; Egalite N; Godard B
    BMC Med Ethics; 2014 Nov; 15():80. PubMed ID: 25410958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical and legal implications of whole genome and whole exome sequencing in African populations.
    Wright GE; Koornhof PG; Adeyemo AA; Tiffin N
    BMC Med Ethics; 2013 May; 14():21. PubMed ID: 23714101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling practice in next generation sequencing research: implications for the ethical oversight of the informed consent process.
    Egalite N; Groisman IJ; Godard B
    J Genet Couns; 2014 Aug; 23(4):661-70. PubMed ID: 24664856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation sequencing in psychiatric research: what study participants need to know about research findings.
    Mathieu G; Groisman IJ; Godard B
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2119-27. PubMed ID: 23725748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Violation of ethical principles in clinical research. Influences and possible solutions for Latin America.
    Cornejo Moreno BA; Gómez Arteaga GM
    BMC Med Ethics; 2012 Dec; 13():35. PubMed ID: 23241478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research participants' perceptions and views on consent for biobank research: a review of empirical data and ethical analysis.
    D'Abramo F; Schildmann J; Vollmann J
    BMC Med Ethics; 2015 Sep; 16():60. PubMed ID: 26354520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving Forward on Consent Practices in Australia.
    McWhirter RE; Eckstein L
    J Bioeth Inq; 2018 Jun; 15(2):243-257. PubMed ID: 29532387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adequacy of informed consent forms in genetic research in Oman: a pilot study.
    Al-Riyami A; Jaju D; Jaju S; Silverman HJ
    Dev World Bioeth; 2011 Aug; 11(2):57-62. PubMed ID: 21266001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considering the Benefits and Risks of Research Participants' Access to Sequence Data.
    Haga SB; Friedman B; Richard G
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):717-721. PubMed ID: 29045186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old Challenges or New Issues? Genetic Health Professionals' Experiences Obtaining Informed Consent in Diagnostic Genomic Sequencing.
    Vears DF; Borry P; Savulescu J; Koplin JJ
    AJOB Empir Bioeth; 2021; 12(1):12-23. PubMed ID: 33017265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical considerations of genetic testing.
    Fleming DA
    J Clin Ethics; 2002; 13(4):316-23. PubMed ID: 12793324
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of consent to return of incidental findings in genomic research.
    Appelbaum PS; Parens E; Waldman CR; Klitzman R; Fyer A; Martinez J; Price WN; Chung WK
    Hastings Cent Rep; 2014; 44(4):22-32. PubMed ID: 24919982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participants' recall and understanding of genomic research and large-scale data sharing.
    Robinson JO; Slashinski MJ; Wang T; Hilsenbeck SG; McGuire AL
    J Empir Res Hum Res Ethics; 2013 Oct; 8(4):42-52. PubMed ID: 24169421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial.
    Shickh S; Clausen M; Mighton C; Casalino S; Joshi E; Glogowski E; Schrader KA; Scheer A; Elser C; Panchal S; Eisen A; Graham T; Aronson M; Semotiuk KM; Winter-Paquette L; Evans M; Lerner-Ellis J; Carroll JC; Hamilton JG; Offit K; Robson M; Thorpe KE; Laupacis A; Bombard Y
    BMJ Open; 2018 Apr; 8(4):e021876. PubMed ID: 29700101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking research ethics.
    Rhodes R
    Am J Bioeth; 2010 Oct; 10(10):19-36. PubMed ID: 20945264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical issues raised by incorporation of genetics into the National Birth Defects Prevention Study.
    Jenkins MM; Rasmussen SA; Moore CA; Honein MA
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):40-6. PubMed ID: 18189287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.